When one of two inhibitory phosphatases for the crucial PI3K B‐cell survival pathway, SHIP1 or PTEN, were inhibited or deleted, impaired survival of CLL cells or worse CLL outcome were reported in mouse models, respectively (Ecker et al, 2021; Schmid et al, 2022). This evidence concerns the gene PTEN and B-cell chronic lymphocytic leukemia.